
Capabilities
The Biosciences group of researchers at ANSTO supports the development and translation of radiopharmaceuticals to improve human health.
Showing 441 - 460 of 1397 results
The Biosciences group of researchers at ANSTO supports the development and translation of radiopharmaceuticals to improve human health.
ANSTO offers reliable and traceable calibration services for radiation survey meters, contamination monitors and electronic personal dosimeters.
ANSTO’s suite of infrastructure and capabilities is ideally suited for solving problems relating to the development and characterisation of advanced materials, and the engineering of manufactured components and processes.
ANSTO’s Innovation Precinct welcomes NSW Government’s $12.5 commitment funding.
Research collaboration with University of Sydney focuses on a personalised approach to cancer treatment.
Do you love science? Here is a competition for you that combines chemistry and creativity! Discover the world of elements and create a poster for your favourite element in this new competition for school aged students.
Southern Sydney Innovation Network (SSIN) is calling all innovators, creators, ideas people and entrepreneurs in Southern Sydney to become part of this community driven, not-for-profit group supporting startups and entrepreneurs.
Datasets from the Aerosol Sampling Program.
Nuclear science is crucial to understanding our universe, our world and ourselves at the atomic level. If we can understand how atoms get together, interact, or can be best combined with other atoms, new, more efficient materials and drugs can be developed.
Role at ANSTO
The SAAFE Program supports early career researchers at PhD and Postdoctoral level to expand research and innovation activities within Human Health, the Environment and the Nuclear Fuel Cycle, to initiate sustainable research networks and linkages to support Australia, New Zealand and France research and innovation.
The radiography program focuses on the development of Neutron Capture Enhanced Particle Therapy (NCEPT) from initial preclinical work, to clinical trials and finally commercial translation and licencing.
Archive of ANSTO research publications, seminars and short talks.
Seven of Australia’s top nuclear medicine professionals have been briefed on ANSTO’s plans to manage radioactive waste, as well as to support nuclear medicine innovation in Australia.
ANSTO announces the recipients of the 2022 organisational awards